Market Overview

This Cannabis ETF Just Dodged Another CannTrust Bullet

This Cannabis ETF Just Dodged Another CannTrust Bullet

Just when it seemed it couldn’t get any worse for CannTrust Holdings Inc (NYSE: CTST) (TSE:TRST), we learned Health Canada has suspended its license to produce and sell cannabis.

While suspended going forward, CannTrust will be allowed to complete the cultivation, harvest and sale of existing lots. Still, it’s a big blow for the company, which is trading around all-time lows.

While many are getting burned, The Cannabis ETF (NYSE: THCX), the fund backed by Jon Najarian and Pete Najarian, seems to have dodged a bullet. The managers decided to drop the stock from its portfolio during its August rebalancing.

Click here for more information about the upcoming Benzinga Cannabis Capital Conference Oct. 22-23 in Chicago.

Matt Markiewicz, Managing Director of The Cannabis ETF, mentioned the fund had dropped CannTrust on Aug. 9.

“Health Canada had to take swift and deliberate action in order to protect not only the consumers of cannabis but to ensure all players are operating on a level playing field," Markiewicz told Benzinga. "While this latest announcement is unfortunate news for current shareholders of the stock, it further underscores the need for diversified exposure to this young and burgeoning industry.”

CannTrust's stock traded down another 7.7% to $1.19 per share at time of publication.

Posted-In: Jon Najarian Matt Markiewicz Pete NajarianCannabis Sector ETFs Markets ETFs Best of Benzinga


Related Articles (THCX + CTST)

View Comments and Join the Discussion!

Cannabis Movers

Sign up for our secret cannabis newsletter!
Never miss out on the breaking news in the Cannabis Industry!